These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 23536681)
21. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses. Amanat F; Duehr J; Oestereich L; Hastie KM; Ollmann Saphire E; Krammer F mSphere; 2018; 3(3):. PubMed ID: 29720525 [TBL] [Abstract][Full Text] [Related]
22. Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. Vincent MJ; Sanchez AJ; Erickson BR; Basak A; Chretien M; Seidah NG; Nichol ST J Virol; 2003 Aug; 77(16):8640-9. PubMed ID: 12885882 [TBL] [Abstract][Full Text] [Related]
23. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread? Seidah NG; Pasquato A; Andréo U Viruses; 2021 Jun; 13(7):. PubMed ID: 34202098 [TBL] [Abstract][Full Text] [Related]
24. Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: ectodomain shedding requires SKI-1 activity. Elagoz A; Benjannet S; Mammarbassi A; Wickham L; Seidah NG J Biol Chem; 2002 Mar; 277(13):11265-75. PubMed ID: 11756446 [TBL] [Abstract][Full Text] [Related]
25. Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents. Olmstead AD; Knecht W; Lazarov I; Dixit SB; Jean F PLoS Pathog; 2012 Jan; 8(1):e1002468. PubMed ID: 22241994 [TBL] [Abstract][Full Text] [Related]
26. Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein. Pullikotil P; Vincent M; Nichol ST; Seidah NG J Biol Chem; 2004 Apr; 279(17):17338-47. PubMed ID: 14970232 [TBL] [Abstract][Full Text] [Related]
28. Multibranch and pseudopeptide approach for design of novel inhibitors of subtilisin kexin isozyme-1. Basak S; Mohottalage D; Basak A Protein Pept Lett; 2006; 13(9):863-76. PubMed ID: 17100641 [TBL] [Abstract][Full Text] [Related]
29. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans. Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. McLay L; Liang Y; Ly H J Gen Virol; 2014 Jan; 95(Pt 1):1-15. PubMed ID: 24068704 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants. Maisa A; Ströher U; Klenk HD; Garten W; Strecker T PLoS Negl Trop Dis; 2009 Jun; 3(6):e446. PubMed ID: 19488405 [TBL] [Abstract][Full Text] [Related]
32. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. Rojek JM; Spiropoulou CF; Campbell KP; Kunz S J Virol; 2007 Jun; 81(11):5685-95. PubMed ID: 17360738 [TBL] [Abstract][Full Text] [Related]
33. A rapid fluorometric assay for the proteolytic activity of SKI-1/S1P based on the surface glycoprotein of the hemorrhagic fever Lassa virus. Basak A; Chrétien M; Seidah NG FEBS Lett; 2002 Mar; 514(2-3):333-9. PubMed ID: 11943176 [TBL] [Abstract][Full Text] [Related]
34. Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins. Martin VK; Droniou-Bonzom ME; Reignier T; Oldenburg JE; Cox AU; Cannon PM J Virol; 2010 Jan; 84(2):1176-82. PubMed ID: 19889757 [TBL] [Abstract][Full Text] [Related]